October 24, 2014 4:44 AM ET


Company Overview of Mendel Biotechnology, Inc.

Company Overview

Mendel Biotechnology, Inc. operates as a plant biotechnology company. The company focuses on developing genetic and chemical solutions for a range of agricultural markets. It offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company has strategic partnerships with Monsanto Corporation, BP, and Bayer CropScience. Mendel Biotechnology, Inc. was founded in 1997 and is based in Hayward, California. It has operations in the United States, Europe, and China.

3935 Point Eden Way

Hayward, CA 94545-3720

United States

Founded in 1997





Key Executives for Mendel Biotechnology, Inc.

Chief Executive Officer
Chief Financial Officer
Age: 59
Senior Vice President of BioEnergy Seeds
Vice President of Human Resources
Compensation as of Fiscal Year 2014.

Mendel Biotechnology, Inc. Key Developments

Mendel Biotechnology Mulls Sale Of Subsidiary

Mendel Biotechnology, Inc. announced its intention to sell its operating subsidiary Mendel Plant Sciences. Mendel Biotechnology has engaged Kirchner Group to advise the Board and lead the acquisition process. "The Board of Directors feels that the Company can best achieve its full potential within the context of a larger organization that has a complementary strategic focus. In this way, it could fully realize its commercial opportunities within the billion-dollar markets that its platform creates," explained Neal Gutterson, President and Chief Executive Officer of Mendel Biotechnology.

Mendel Biotechnology, Inc. and Fundacion MEDINA Enter into a License Collaboration

Mendel Biotechnology, Inc. and Fundacion MEDINA have entered into a license collaboration that will enable Mendel to identify novel biostimulant products. Biostimulants are a new category of agricultural chemicals derived from natural sources and applied as seed treatments or foliar applications to improve crop productivity through improved stress tolerance, water and nutrient use efficiency, and overall growth and yield. These natural products can be brought to the market more quickly and with lower regulatory costs than synthetic chemistries. Under the agreement, MEDINA will provide Mendel with microbial extracts from elite culture collections. Mendel will run its proprietary screens on these collections to identify natural products with crop performance benefits. Those that enhance drought tolerance and increase yield are targeted as the first products from these screens.

E. I. du Pont de Nemours and Company Signs Pact with Mendel Biotechnology, Inc. to Develop Water-Efficient Corn Trait

E. I. du Pont de Nemours and Company's Pioneer seed unit and Mendel Biotechnology, Inc. have entered into a license collaboration to evaluate and commercialize new gene leads for increased water-use efficiency and improved photosynthesis in corn. Under the agreement, the two companies will evaluate new gene leads and test them for yield-enhancement traits in Pioneer-brand corn products. The gene leads were identified by Mendel in its plant physiology platform.

Similar Private Companies By Industry

Company Name Region
Universal Preservation Technologies, Inc. United States
Pelican Therapeutics, Inc. United States
BioMarker Pharmaceuticals, Inc. United States
Advanced Photodynamic Technologies, Inc. United States
ImmuneRegen BioSciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mendel Biotechnology, Inc., please visit www.mendel.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.